Erratum to: Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study

被引：0

作者：

Laura Ordoñez-Boschetti

Roberto Rey

Ana Cruz

Arijit Sinha

Tracy Reynolds

Nadina Frider

Regina Alvarenga

机构：

[1] Consultorio de Medicina Especializada del Sector Privado,

[2] Instituto Argentino de Investigación Neurológica,undefined

[3] Centro de Investigaciones Médicas Hospital Nacional Alberto Sabogal Sologuren,undefined

[4] Novartis Healthcare Pvt. Ltd.,undefined

[5] Novartis Pharma AG,undefined

[6] Novartis LAtinAmerica and Canada Region,undefined

[7] MS Hospital Da Lagoa,undefined

来源：

Advances in Therapy | 2015年 / 32卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：636 / 636

共 50 条

[21] Safety, pharmacodynamics, and activity of rituximab in patients with relapsing-remitting multiple sclerosis: a phase I, multicentre, open-label clinical trial [J].

Bar-Or, A. ;

Calabresi, P. ;

Arnold, D. L. ;

Markowitz, C. ;

Shafer, S. ;

Kasper, L. ;

Waubant, E. ;

Gazda, S. ;

Fox, R. ;

Panzara, M. ;

Sarkar, N. ;

Agarwal, S. ;

Smith, C. .

MULTIPLE SCLEROSIS, 2007, 13 :S165-S166

[22] Safety, Tolerability, and Efficacy of Oral Therapies for Relapsing-Remitting Multiple Sclerosis [J].

Oh, Jiwon ;

O'Connor, Paul W. .

CNS DRUGS, 2013, 27 (08) :591-609

[23] A phase I, open-label, multicenteir study to evaluate the safety and activity of rituximab in adults with relapsing-remitting multiple sclerosis (RRMS) [J].

Bar-Or, Amit ;

Calabresi, Peter ;

Arnold, Douglas ;

Markowitz, Clyde ;

Shafer, Stuart ;

Kasper, Lloyd ;

Waubant, Emmanuelle ;

Gazda, Suzanne ;

Fox, Robert ;

Sarkar, Neena ;

Panzara, Michael ;

Smith, Craig .

NEUROLOGY, 2007, 68 (12) :A84-A84

[24] CONNECT: an open-label, active-controlled dimethyl fumarate study in pediatric patients with relapsing-remitting multiple sclerosis [J].

Maghzi, A. -H. ;

Levin., S. ;

Alroughani, R. ;

Deiva, K. ;

Pozzili, C. ;

Lyons, J. ;

Mokliatchouk, O. ;

Pultz, J. ;

N'Dure, F. ;

Liu, S. ;

Badwan, R. ;

Branco, F. ;

Franchimont, N. ;

Hanna, J. ;

Scaramozza, M. ;

Vermersch, P. .

MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) :194-195

[25] Efficacy of fingolimod in patients with highly active relapsing-remitting multiple sclerosis [J].

Derfuss, T. ;

Bergvall, N. K. ;

Sfikas, N. ;

Tomic, D. L. .

CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (09) :1687-1691

[26] Safety, Tolerability, and Efficacy of Oral Therapies for Relapsing-Remitting Multiple Sclerosis [J].

Jiwon Oh ;

Paul W. O’Connor .

CNS Drugs, 2013, 27 :591-609

[27] The experience of using fingolimod (gilenya) in patients with relapsing-remitting multiple sclerosis [J].

Kotov, S. V. ;

Fedorova, S. I. ;

Yakushina, T. I. ;

Lizhdvoy, V. Yu .

ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (02) :74-78

[28] Safety and tolerability of fingolimod 0.5 mg during the first 4 months of administration in patients with relapsing forms of multiple sclerosis. Results from the open-label, multicentre FIRST study [J].

Kappos, L. ;

Comi, G. ;

Palace, J. ;

Siever, A. ;

Marrosu, M. ;

Mehling, M. ;

Gottschalk, R. ;

Bijarnia, M. ;

Keil, A. ;

Tomic, D. ;

von Rosenstiel, P. ;

Gold, R. .

JOURNAL OF NEUROLOGY, 2012, 259 :S64-S65

[29] Reasons for switching to fingolimod in patients relapsing-remitting multiple sclerosis in France: the ESGILE study [J].

Tourbah, Ayman ;

Papeix, Caroline ;

Tourniaire, Patricia ;

Rerat, Karin ;

Meite, Mohamed ;

Durand, Barbara ;

Lamy, Fabienne ;

Chouette, Isabelle ;

Mekies, Claude ;

Aboab, Jennyfer ;

Al Khedr, Abdullatif ;

Carpentier, Amer Al Najjar ;

Androdias, Geraldine ;

Benrabah, Rabah ;

Biotti, Damien ;

Bohotin, Valentin ;

Bonnan, Mickael ;

Bonnet, Cecilia ;

Boulesteix, Jean Marc ;

Brassat, David ;

Busson, Philippe ;

Camu, William ;

Castelnovo, Giovanni ;

Chapuis, Stephane ;

Clavelou, Pierre ;

Convers, Philippe ;

Coustans, Marc ;

Creange, Alain ;

Delassaux, Sebastien ;

Diot, Eric ;

Djerdi, Madjid ;

Drouet, Thomas ;

Delalande, Sophie Dufour ;

Pottier, Corinne Dupel ;

Ferriby, Didier ;

Gaida, Philippe ;

Gal, Guillaume ;

Giraud, Pierric ;

Guilloton, Laurent ;

Hascar, Tijani ;

Heinzlef, Olivier ;

Rouaud, Violaine Jaffrenou ;

Jager, Alain ;

Kubler, Christophe ;

Le Coz, Patrick ;

Frenay, Christine Lebrun ;

Maillart, Elisabeth ;

Vioud, Paris Marcel Maillet ;

Malkoun, Imad ;

Manchon, Eric .

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46

[30] Safety, efficacy, and tolerability of alemtuzumab in pediatric patients with active relapsing-remitting multiple sclerosis: The LemKids study [J].

Chitnis, Tanuja ;

Arnold, Douglas L. ;

Quartier, Pierre ;

Chirieac, Magdalena ;

Hu, Wenruo ;

Jurgensen, Stephanie ;

Havrdova, Eva K. .

MULTIPLE SCLEROSIS JOURNAL, 2025, 31 (01) :23-35

← 1 2 3 4 5 →